CIK 0001411690
- Non-accelerated filer
- Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261756290
- Phone
- +1 858-888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 65,789 shares at $0.76 ($50,000)
- 4 Open-market buy President and CEO bought 15,000 shares at $0.64 ($9,639)
- 4 Open-market buy Chief Financial Officer bought 50,000 shares at $0.67 ($33,415)
- 4 Shares withheld for taxes Chief Operating Officer gave up 41,496 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 50,141 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President and CEO acquired 300,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 120,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 120,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 105,000 shares (grant or award)
- 4 Open-market sale Director sold 20,000 shares at $3.62 ($72,402)
- 4/A Derivatives Options or other derivatives
Page 5 of 12 · 230 filings